PROPANC BIOPHARMA, INC. Financing Cash Flow
PROPANC BIOPHARMA, INC. (PPCB) reported Financing Cash Flow of $4.47 million for the 9-month period ending 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $981.61K, a 565.57% increase year-over-year.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $965.10K, a 1660.62% increase year-over-year.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $2.53M, a 1071.43% increase year-over-year.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $72.76K, a 71.01% decline year-over-year.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for fiscal 2023 was $1.11M, a 25.29% decline from fiscal 2022.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for fiscal 2022 was $1.49M, a 40.90% increase from fiscal 2021.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for fiscal 2021 was $1.06M, a 44.03% decline from fiscal 2020.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) financing activities for fiscal 2020 was $1.89M, a 10.78% decline from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 51 month | Net Cash Provided by (Used in) Financing Activities 54 month | Net Cash Provided by (Used in) Financing Activities 57 month | Net Cash Provided by (Used in) Financing Activities 60 month | Net Cash Provided by (Used in) Financing Activities 63 month | Net Cash Provided by (Used in) Financing Activities 66 month | Net Cash Provided by (Used in) Financing Activities 68 month | Net Cash Provided by (Used in) Financing Activities 72 month | Net Cash Provided by (Used in) Financing Activities 75 month | Net Cash Provided by (Used in) Financing Activities 77 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $981.61K derived: S-1 9 month − S-1 6 month · filed 2026-07-17 | $1.95M derived: sum of 2 quarters · filed 2026-07-17 | $4.47M S-1 · filed 2026-07-17 | $4.55M derived: sum of 4 quarters · filed 2026-07-17 | ||||||||||||
| 2025-12-31 | $965.10K derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10 | $3.49M S-1 · filed 2026-04-10 | $3.56M derived: sum of 3 quarters · filed 2026-07-17 | $3.71M derived: sum of 4 quarters · filed 2026-07-17 | ||||||||||||
| 2025-09-30 | $2.53M 10-Q · filed 2025-11-14 | $2.60M derived: sum of 2 quarters · filed 2026-07-17 | $2.75M derived: sum of 3 quarters · filed 2026-07-17 | $2.80M derived: sum of 4 quarters · filed 2026-07-17 | ||||||||||||
| 2025-06-30 | $72.76K derived: S-1 12 month − S-1 9 month · filed 2026-07-17 | $220.24K derived: sum of 2 quarters · filed 2026-07-17 | $275.06K derived: sum of 3 quarters · filed 2026-07-17 | $490.76K S-1 · filed 2026-07-17 | ||||||||||||
| 2025-03-31 | $147.49K derived: S-1 9 month − S-1 6 month · filed 2026-07-17 | $202.30K derived: sum of 2 quarters · filed 2026-07-17 | $418.00K S-1 · filed 2026-07-17 | $483.00K 10-Q · filed 2025-05-15 | $668.97K derived: sum of 4 quarters · filed 2026-07-17 | |||||||||||
| 2024-12-31 | $54.82K derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10 | $270.51K S-1 · filed 2026-04-10 | $295.51K 10-Q · filed 2025-02-14 | $521.49K derived: sum of 3 quarters · filed 2026-07-17 | $588.13K derived: sum of 4 quarters · filed 2026-07-17 | |||||||||||
| 2024-09-30 | $215.70K 10-Q · filed 2025-11-14 | $466.67K derived: sum of 2 quarters · filed 2026-07-17 | $533.32K derived: sum of 3 quarters · filed 2026-07-17 | $807.25K derived: sum of 4 quarters · filed 2026-07-17 | ||||||||||||
| 2024-06-30 | $250.97K derived: S-1 12 month − 10-Q 9 month · filed 2026-07-17 | $317.62K derived: sum of 2 quarters · filed 2026-07-17 | $591.55K derived: sum of 3 quarters · filed 2026-07-17 | $941.89K S-1 · filed 2026-07-17 | ||||||||||||
| 2024-03-31 | $66.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $340.57K derived: sum of 2 quarters · filed 2025-05-15 | $690.92K 10-Q · filed 2025-05-15 | $790.92K derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | $273.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $624.28K 10-Q · filed 2025-02-14 | $724.28K derived: sum of 3 quarters · filed 2025-02-14 | $993.78K derived: sum of 4 quarters · filed 2025-02-14 | ||||||||||||
| 2023-09-30 | $350.35K 10-Q · filed 2024-11-14 | $450.35K derived: sum of 2 quarters · filed 2024-11-14 | $719.85K derived: sum of 3 quarters · filed 2024-11-14 | $969.85K derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||
| 2023-06-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $369.50K derived: sum of 2 quarters · filed 2024-09-30 | $619.50K derived: sum of 3 quarters · filed 2024-09-30 | $1.11M 10-K · filed 2024-09-30 | ||||||||||||
| 2023-03-31 | $269.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $519.50K derived: sum of 2 quarters · filed 2024-05-15 | $1.01M 10-Q · filed 2024-05-15 | $1.39M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2022-12-31 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-20 | $744.22K 10-Q · filed 2024-02-20 | $1.12M derived: sum of 3 quarters · filed 2024-02-20 | $1.45M derived: sum of 4 quarters · filed 2024-02-20 | ||||||||||||
| 2022-09-30 | $494.22K 10-Q · filed 2023-11-14 | $868.50K derived: sum of 2 quarters · filed 2023-11-14 | $1.20M derived: sum of 3 quarters · filed 2023-11-14 | $1.55M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||
| 2022-06-30 | $374.29K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $701.29K derived: sum of 2 quarters · filed 2023-09-28 | $1.06M derived: sum of 3 quarters · filed 2023-09-28 | $1.49M 10-K · filed 2023-09-28 | ||||||||||||
| 2022-03-31 | $327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $681.50K derived: sum of 2 quarters · filed 2023-05-15 | $1.12M 10-Q · filed 2023-05-15 | $1.37M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||
| 2021-12-31 | $354.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $789.50K 10-Q · filed 2023-02-10 | $1.04M derived: sum of 3 quarters · filed 2023-02-10 | $1.49M derived: sum of 4 quarters · filed 2023-02-10 | ||||||||||||
| 2021-09-30 | $435.00K 10-Q · filed 2022-11-14 | $685.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.14M derived: sum of 3 quarters · filed 2022-11-14 | $1.33M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | $700.00K derived: sum of 2 quarters · filed 2022-09-28 | $900.00K derived: sum of 3 quarters · filed 2022-09-28 | $1.06M 10-K · filed 2022-09-28 | ||||||||||||
| 2021-03-31 | $450.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $650.00K derived: sum of 2 quarters · filed 2022-05-16 | $808.04K 10-Q · filed 2022-05-16 | $1.23M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $358.04K 10-Q · filed 2022-02-14 | $783.03K derived: sum of 3 quarters · filed 2022-02-14 | $1.12M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||
| 2020-09-30 | $158.04K 10-Q · filed 2021-11-12 | $583.03K derived: sum of 2 quarters · filed 2021-11-12 | $918.28K derived: sum of 3 quarters · filed 2021-11-12 | $1.18M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||||
| 2020-06-30 | $424.99K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $760.24K derived: sum of 2 quarters · filed 2021-09-28 | $1.03M derived: sum of 3 quarters · filed 2021-09-28 | $1.89M 10-K · filed 2021-09-28 | ||||||||||||
| 2020-03-31 | $335.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $600.25K derived: sum of 2 quarters · filed 2021-05-14 | $1.47M 10-Q · filed 2021-05-14 | $1.66M derived: sum of 4 quarters · filed 2021-05-14 | ||||||||||||
| 2019-12-31 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | $1.13M 10-Q · filed 2021-02-12 | $1.33M derived: sum of 3 quarters · filed 2021-02-12 | $2.02M derived: sum of 4 quarters · filed 2021-02-12 | ||||||||||||
| 2019-09-30 | $865.00K 10-Q · filed 2020-11-16 | $1.06M derived: sum of 2 quarters · filed 2020-11-16 | $1.76M derived: sum of 3 quarters · filed 2020-11-16 | $2.50M derived: sum of 4 quarters · filed 2020-11-16 | ||||||||||||
| 2019-06-30 | $198.40K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-01 | $892.67K derived: sum of 2 quarters · filed 2020-10-01 | $1.64M derived: sum of 3 quarters · filed 2020-10-01 | $2.12M 10-K · filed 2020-10-01 | ||||||||||||
| 2019-03-31 | $694.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $1.44M derived: sum of 2 quarters · filed 2020-05-15 | $1.92M 10-Q · filed 2020-05-15 | $2.42M derived: sum of 4 quarters · filed 2020-05-15 | ||||||||||||
| 2018-12-31 | $745.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $1.23M 10-Q · filed 2020-02-14 | $1.73M derived: sum of 3 quarters · filed 2020-02-14 | $2.35M derived: sum of 4 quarters · filed 2020-02-14 | ||||||||||||
| 2018-09-30 | $480.42K 10-Q · filed 2019-11-14 | $983.65K derived: sum of 2 quarters · filed 2019-11-14 | $1.60M derived: sum of 3 quarters · filed 2019-11-14 | $1.98M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||||||
| 2018-06-30 | $503.23K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-15 | $1.12M derived: sum of 2 quarters · filed 2019-10-15 | $1.50M derived: sum of 3 quarters · filed 2019-10-15 | $2.40M 10-K · filed 2019-10-15 | ||||||||||||
| 2018-03-31 | $619.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | $999.25K derived: sum of 2 quarters · filed 2019-05-15 | $1.89M 10-Q · filed 2019-05-15 | |||||||||||||
| 2017-12-31 | $380.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $1.27M 10-Q · filed 2019-02-14 | ||||||||||||||
| 2017-09-30 | $894.00K 10-Q · filed 2018-11-13 | |||||||||||||||
| 2017-06-30 | $2.10M 10-K · filed 2018-09-17 | |||||||||||||||
| 2014-03-31 | $45.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20 | $23.53K derived: sum of 2 quarters · filed 2014-05-20 | $136.75K 10-Q · filed 2014-05-20 | $166.22K derived: sum of 4 quarters · filed 2014-05-20 | $2.87M 10-Q · filed 2014-05-20 | |||||||||||
| 2013-12-31 | -$22.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $90.86K 10-Q · filed 2014-02-14 | $120.33K derived: sum of 3 quarters · filed 2014-02-14 | $145.30K derived: sum of 4 quarters · filed 2014-05-20 | $2.83M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $113.22K 10-Q · filed 2013-11-14 | $142.69K derived: sum of 2 quarters · filed 2013-11-14 | $167.66K derived: sum of 3 quarters · filed 2014-05-20 | $167.14K derived: sum of 4 quarters · filed 2014-05-20 | $2.85M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $29.47K derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15 | $54.44K derived: sum of 2 quarters · filed 2014-05-20 | $53.92K derived: sum of 3 quarters · filed 2014-05-20 | $128.47K 10-K · filed 2013-10-15 | $2.74M 10-K · filed 2013-10-15 | |||||||||||
| 2013-03-31 | $24.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20 | $24.45K derived: sum of 2 quarters · filed 2014-05-20 | $98.99K 10-Q · filed 2014-05-20 | $115.61K derived: sum of 4 quarters · filed 2014-05-20 | $2.71M 10-Q · filed 2013-05-20 | |||||||||||
| 2012-12-31 | -$519.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $74.03K 10-Q · filed 2014-02-14 | $90.65K derived: sum of 3 quarters · filed 2014-02-14 | $164.03K derived: sum of 4 quarters · filed 2014-02-14 | $2.68M 10-Q · filed 2013-02-20 | |||||||||||
| 2012-09-30 | $74.54K 10-Q · filed 2013-11-14 | $91.17K derived: sum of 2 quarters · filed 2013-11-14 | $164.54K derived: sum of 3 quarters · filed 2013-11-14 | $193.11K derived: sum of 4 quarters · filed 2013-11-14 | $2.68M 10-Q · filed 2012-11-19 | |||||||||||
| 2012-06-30 | $16.62K derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15 | $90.00K derived: sum of 2 quarters · filed 2013-10-15 | $118.56K derived: sum of 3 quarters · filed 2013-10-15 | $170.33K 10-K · filed 2013-10-15 | $2.61M 10-K · filed 2012-10-15 | |||||||||||
| 2012-03-31 | $73.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20 | $101.94K derived: sum of 2 quarters · filed 2013-05-20 | $153.71K 10-Q · filed 2013-05-20 | $309.05K derived: sum of 4 quarters · filed 2013-05-20 | $2.59M 10-Q · filed 2012-05-21 | |||||||||||
| 2011-12-31 | $28.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-20 | $80.33K 10-Q · filed 2013-02-20 | $235.67K derived: sum of 3 quarters · filed 2013-02-20 | $235.49K derived: sum of 4 quarters · filed 2013-02-20 | $2.52M 10-Q/A · filed 2012-03-07 | |||||||||||
| 2011-09-30 | $51.77K 10-Q · filed 2012-11-19 | $207.11K derived: sum of 2 quarters · filed 2012-11-19 | $206.93K derived: sum of 3 quarters · filed 2012-11-19 | |||||||||||||
| 2011-06-30 | $155.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15 | $155.16K derived: sum of 2 quarters · filed 2012-10-15 | $1.42M 10-K · filed 2012-10-15 | |||||||||||||
| 2011-03-31 | -$178.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-05-21 | $1.27M 10-Q · filed 2012-05-21 | ||||||||||||||
| 2010-12-31 | $1.27M 10-Q/A · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |